Learn more

PEPGEN CORP

Overview
  • Total Patents
    81
About

PEPGEN CORP has a total of 81 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are AMCURE GMBH, TOPOTARGET GERMANY AG and ISOTECHNIKA PHARMA INC.

Patent filings per year

Chart showing PEPGEN CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Liu Chih-Ping 50
#2 Villarete Lorelie H 41
#3 Sokawa Yoshihiro 15
#4 Campos Jackeline 11
#5 Pontzer Carol H 7
#6 Johnson Howard M 7
#7 Lopez Henry W 6
#8 Kirnon Stephen N 6
#9 Liu Chih Ping 5
#10 Manning Mark C 4

Latest patents

Publication Filing date Title
WO2008021536A2 Use of interferon tau for the manufacture of a medicament in combination with interferon-alpha or interferon-beta for reduction of their adverse effects
WO2008021487A1 Combination treatment method with interferon-tau
US2007237743A1 Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs
US2007081991A1 Compositions and methods for modulation of immune responses
KR20080037656A Low-toxicity, long-circulating chimeras of human interferon-alpha analogs and interferon tau
US2006257363A1 Treatment using an interferon
CA2602850A1 Ocular delivery of interferon-tau
US2006134750A1 Method of treatment using interferon-tau
US2006078942A1 Method of treatment using interferon-tau
US2005265968A1 Method of treating IL-10 deficiency
AU2005221682A1 Pharmaceutical compositions comprising interferon-tau
TW200533369A Applications of treatment using interferon-tau
TW200518768A Methods for treatment of obesity and for promotion of weight loss
CN1897968A Method of treatment using interferon-tau
US7083782B2 Method of treatment using interferon-tau
US7105154B2 Method of treatment using interferon-tau
CA2501133A1 Oral formulations for proteins and polypeptides
CN1615154A Oral administration of interferon-TAU
EP1425409A2 Hybrid interferon/interferon tau proteins, compositions and methods of use
WO02088161A1 Method for expression of human interferon alpha 1 in pichia pa storis